BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6155429)

  • 21. Reciprocal interference between milk-transmitted mammary tumor virus and Friend leukemia viruses in mice: possible role of the interferon system.
    Basolo F; Toniolo A; Bistocchi M; Fontanini G; Squartini F
    Cancer Res; 1986 Aug; 46(8):4064-70. PubMed ID: 2425940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression induced in vitro by cell-free extracts of Friend leukemia virusinfected splenocytes.
    Specter S; Patel C; Friedman H
    J Natl Cancer Inst; 1976 Jan; 56(1):143-7. PubMed ID: 768498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunotherapy of Friend leukemia with antiserum (author's transl)].
    Lynn TC; Metzgar RS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):94-104. PubMed ID: 7449527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia.
    Wirth JJ; Levy MH; Wheelock EF
    J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on the mechanism of interference between Friend leukemia and Sindbis viruses in tissue culture.
    Pogodina VV; Senyuta NB; Karmysheva VY; Korolev MB; Satalkina MI; Kiseleva LL; Merekalova ZI; Mazurenko NP
    Neoplasma; 1976; 23(1):61-70. PubMed ID: 775350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of Friend leukaemia antigens in chronically-infected cells treated with interferon.
    Ramoni C; Rossi GB; Matarese GP; Dole A
    J Gen Virol; 1977 Nov; 37(2):285-96. PubMed ID: 562923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain difference in immune response of the rat to NRK cells infected with spleen focus-forming virus of the Friend leukaemia virus complex.
    Kai K; Yoshida M; Odaka T
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2169-76. PubMed ID: 6413646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody.
    Ihle JN; Hanna MG; Schafer W; Hunsmann G; Bolognesi DP; HUPER G
    Virology; 1975 Jan; 63(1):60-7. PubMed ID: 46126
    [No Abstract]   [Full Text] [Related]  

  • 29. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 30. Surface expression of murine leukemia virus structural polypeptides on host cells and the virion.
    Schneider J; Hunsmann G
    Int J Cancer; 1978 Aug; 22(2):204-13. PubMed ID: 81184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Model studies on virus-induced tumors and their immunological treatment (author's transl)].
    Schäfer W
    Klin Wochenschr; 1977 Sep; 55(17):835-46. PubMed ID: 198602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies recognizing structural components of murine retroviruses including an FMR antigen on protein p12.
    Gambke C; Senn HP; Hunsmann G; Schumann G; Moroni C; Alkan SS
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1507-17. PubMed ID: 6206201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complement.
    Gorman NT; Lachmann PJ
    Clin Exp Immunol; 1982 Dec; 50(3):507-14. PubMed ID: 6762269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors from lymphoid cell tumor affecting immune responses.
    Specter S; Schneider R; Friedman H
    Ann N Y Acad Sci; 1979; 332():531-8. PubMed ID: 394642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.
    Ihle JN; Collins JJ; Lee JC; Fischinger PJ; Moennig V; Schäfer W; Hanna MG; Bolognesi DP
    Virology; 1976 Nov; 75(1):74-87. PubMed ID: 982854
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma.
    He JY; Cheng HJ; Wang YF; Zhu YT; Li GQ
    J Virol Methods; 2008 Feb; 147(2):345-50. PubMed ID: 18068233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
    Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
    Hanna MG; Ihle JN; Lee JC
    Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neutralization of transmissible gastroenteritis virus by normal heterotypic serum.
    Pike BV; Garwes DJ
    J Gen Virol; 1979 Feb; 42(2):279-87. PubMed ID: 217957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.